ATE510905T1 - Verfahren zur isolierung von bipotenten lebervorläuferzellen - Google Patents

Verfahren zur isolierung von bipotenten lebervorläuferzellen

Info

Publication number
ATE510905T1
ATE510905T1 AT00968708T AT00968708T ATE510905T1 AT E510905 T1 ATE510905 T1 AT E510905T1 AT 00968708 T AT00968708 T AT 00968708T AT 00968708 T AT00968708 T AT 00968708T AT E510905 T1 ATE510905 T1 AT E510905T1
Authority
AT
Austria
Prior art keywords
progenitors
cells
hepatic
antigen
cell
Prior art date
Application number
AT00968708T
Other languages
English (en)
Inventor
Hiroshi Kubota
Lola Reid
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE510905T1 publication Critical patent/ATE510905T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00968708T 2000-10-03 2000-10-03 Verfahren zur isolierung von bipotenten lebervorläuferzellen ATE510905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/027429 WO2002028997A2 (en) 2000-10-03 2000-10-03 Methods of isolating bipotent hepatic progenitor cells

Publications (1)

Publication Number Publication Date
ATE510905T1 true ATE510905T1 (de) 2011-06-15

Family

ID=21741847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968708T ATE510905T1 (de) 2000-10-03 2000-10-03 Verfahren zur isolierung von bipotenten lebervorläuferzellen

Country Status (11)

Country Link
EP (1) EP1325112B1 (de)
JP (1) JP2004510432A (de)
CN (1) CN1258589C (de)
AT (1) ATE510905T1 (de)
AU (2) AU7858200A (de)
CA (1) CA2424781C (de)
DK (1) DK1325112T3 (de)
ES (1) ES2367005T3 (de)
HK (1) HK1054569B (de)
IL (2) IL155249A0 (de)
WO (1) WO2002028997A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187133A1 (en) 1999-10-01 2002-12-12 Hiroshi Kubota Methods of isolating bipotent hepatic progenitor cells
CN1461341A (zh) * 2000-10-03 2003-12-10 北卡罗来纳大学 肝祖先细胞克隆生长的方法
KR100947911B1 (ko) 2001-03-27 2010-03-17 버텍스 파마슈티칼스 인코포레이티드 Ｈｃｖ 감염에 유용한 조성물 및 방법
US7211404B2 (en) 2001-06-22 2007-05-01 Stem Cells, Inc. Liver engrafting cells, assays, and uses thereof
CA2553303C (en) * 2004-01-14 2014-06-10 Novahep Ab Human hepatic progenitor cells and methods of use thereof
CN102083967B (zh) * 2007-07-20 2013-05-15 塞拉提斯股份公司 经由定型内胚层(DE-hep)衍生自人胚泡衍生干细胞的新肝细胞群体
EP3321286B1 (de) * 2011-08-23 2021-01-06 Roche Glycart AG Bispezifische antigenbindende moleküle zur t-zellen-aktivierung
PL3140393T3 (pl) * 2014-08-28 2023-11-06 Cellaïon SA Sposób wytwarzania komórek progenitorowych dorosłej wątroby
SG11201704291QA (en) * 2014-11-26 2017-06-29 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
JP6704617B2 (ja) * 2016-01-29 2020-06-03 北海道公立大学法人 札幌医科大学 小型肝細胞の継代培養方法
CN109385394A (zh) * 2018-11-02 2019-02-26 大连理工大学 一种提取、分离和培养同体异种肝原代细胞的方法
AU2019398753A1 (en) * 2018-12-14 2021-08-05 Promethera Therapeutics Sa Cell composition comprising liver progenitor cells expressing HLA-E

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
KR100873690B1 (ko) * 1999-01-19 2008-12-12 유니버시티 오브 노스캐롤라이나 앳 채플 힐 인간 간 전구세포

Also Published As

Publication number Publication date
CA2424781C (en) 2018-11-06
WO2002028997A2 (en) 2002-04-11
CN1258589C (zh) 2006-06-07
EP1325112B1 (de) 2011-05-25
WO2002028997A3 (en) 2002-09-12
HK1054569A1 (en) 2003-12-05
EP1325112A2 (de) 2003-07-09
CA2424781A1 (en) 2002-04-11
CN1461340A (zh) 2003-12-10
ES2367005T3 (es) 2011-10-27
JP2004510432A (ja) 2004-04-08
DK1325112T3 (da) 2011-09-12
AU2000278582B2 (en) 2007-08-30
AU7858200A (en) 2002-04-15
IL155249A (en) 2011-12-29
IL155249A0 (en) 2003-11-23
HK1054569B (en) 2012-03-02

Similar Documents

Publication Publication Date Title
Driscoll et al. Establishment of immortalized alveolar type II epithelial cell lines from adult rats
Zeddou et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood
Austin et al. Hepatic regeneration from hematopoietic stem cells
Shafritz et al. Liver stem cells and model systems for liver repopulation
Wei et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells
DK1325112T3 (da) Fremgangsmåde til isolering af bipotente hepatiske progenitorceller
Bonilla et al. Functional neural stem cells derived from adult bone marrow
Langergraber et al. How old are chimpanzee communities? Time to the most recent common ancestor of the Y-chromosome in highly patrilocal societies
Pfeiffer et al. Differentiation of a teratocarcinoma line: preferential development of cholinergic neurons.
Cordeiro-Spinetti et al. Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation
DK1147179T3 (da) Humane lever-progenitorer
ATE449837T1 (de) Abstammungs-spezifische zellen und vorläuferzellen
WO2003104411A3 (en) BIOARTIFICIAL LIVER SYSTEM
DE69739480D1 (de) Menschliche hämatopoietische stamm und vorläuferzellantigen und methoden zu dessen verwendung
JP2012507304A5 (de)
O'Connor et al. Differentiation rather than aging of muscle stem cells abolishes their telomerase activity
BRPI0710339A2 (pt) método de modulação de uma reação imunólogica, método de redução e extrato
Orr et al. Stem cell–derived respiratory epithelial cell cultures as human disease models
Kim et al. Recent advances and applications of human lung alveolar organoids
LeBleu et al. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome
ATE310816T1 (de) Verfahren zur bestimmung einer genfunktion
Reynolds et al. Lung epithelial healing: a modified seed and soil concept
Lambert et al. The influence of three-dimensional structure on naïve T cell homeostasis and aging
ATE548447T1 (de) Menschlicher hepatische vorläuferzellen und verfahren zur verwendung davon
Pouliot et al. Optimization of a transplant model to assess skin reconstitution from stem cell‐enriched primary human keratinocyte populations

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1325112

Country of ref document: EP